Ronit Simantov is CMO & Chief Scientific Officer of Gamida Cell Ltd.
Person profile
Roles
Gamida Cell
CMO & Chief Scientific Officer
Tempest Therapeutics
Director
Address
New Haven, Connecticut
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Gamida Cell Ltd.
2 Feb 24
4
Tempest Therapeutics, Inc.
20 Jun 23
4
Gamida Cell Ltd.
10 Feb 23
3
Gamida Cell Ltd.
10 Feb 23
4
Tempest Therapeutics, Inc.
22 Jun 22
4
Tempest Therapeutics, Inc.
10 Aug 21
3
Tempest Therapeutics, Inc.
10 Aug 21
4
Clovis Oncology, Inc.
13 Jul 21
3
Clovis Oncology, Inc.
13 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jun 23 | TPST Tempest Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.42 | 8,200 | 11.64 k | 8,200 |
8 Feb 23 | GMDAQ Gamida Cell | Ordinary Shares | Grant | Acquire A | No | No | 0 | 58,100 | 0.00 | 175,577 |
8 Feb 23 | GMDAQ Gamida Cell | Employee Share Option Ordinary Shares | Grant | Acquire A | No | No | 1.59 | 116,340 | 184.98 k | 116,340 |